Clinical Guidance

This document from the Reproductive Health Access Project provides a detailed protocol for medication abortion using mifepristone and misoprostol.

This chart guides clinical decisions in medication abortion management when an ultrasound does not show an intrauterine pregnancy.

ACOG’s clinical practice bulletin provides evidence-based guidelines on medication abortion for pregnancies up to 70 days gestation, including protocols and safety considerations.

This resource offers internal medicine physicians an updated overview of medication abortion practices in 2024, highlighting key clinical considerations and guidelines.

This resource from the Society for Maternal Fetal Medicine explains federal activities and litigation activity impacting medical emergencies and the application of EMTALA in the context of abortion care access.

This clinical recommendation covers medication abortion protocols for pregnancies between approximately 14 and 27 weeks of gestation, including safety considerations and clinical monitoring.

Review this document from the Reproductive Health Access Project for coding guidelines for medication abortion billing and documentation.

This Reproductive Health Access Project resource details coding for manual vacuum aspiration abortion procedures.

This document outlines cancer care considerations related to reproductive health, offering physicians guidance on integrating fertility preservation and reproductive planning in oncology treatment.

This research article discusses clinical recommendations for cancer patients regarding reproductive health, including fertility preservation strategies and management of pregnancy during cancer treatment.